220 ABSTRACT: Angiotensin-converting enyzme inhibitors (ACEIs) are commonly used to treat cardiovascular disorders. The use of ACEIs for hypertension is well established, although these agents have not proven to be superior to other antihypertensive agents. The use of ACEIs in heart failure is also well established, and has proven to reduce morbidity and mortality. ACEIs are now routinely used ...

Background: Controversial data concerning the elevation of serum angiotensin-converting enzyme in psoriasis are reported in the literature. In order to verify whether this abnormality exists in Iranian patients, we performed this study. Method: Serum angiotensin-converting enzyme level was measured in 40 psoriatics. According to clinical forms of psoriasis, patients were further divided into th...

1. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51:1624--30. 2. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165:1637--42. 3. Banerji A, Clark S, ...

Introduction The prognosis of patients with heart failure has significantly improved in the past decades with the advent of therapies such as angiotensinconverting enzyme (ACE) inhibitors, betablockers, mineralocorticoid receptor antagonists (MRAs), ivabradine, LCZ696 and with devices such as implantable cardioverterdefibrillator (ICD) and cardiac resynchronization therapy devices (CRT).[1] By ...

The potential interaction between acetylsalicylic acid and angiotensin-converting enzyme inhibitors in patients with heart failure has received considerable attention lately. Opposing effects on prostaglandin synthesis and metabolism form the theoretical basis of an interaction. A review of the available literature revealed conflicting data from animal studies, human pharmacological studies, an...